| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000047362 |
| Receipt No. | R000054018 |
| Scientific Title | Study of liver surgical anatomy using 3D simulation software |
| Date of disclosure of the study information | 2022/04/01 |
| Last modified on | 2022/10/03 (Ver. 2) |
| Basic information | ||
| Public title | Study of liver surgical anatomy using 3D simulation software | |
| Acronym | Study of liver surgical anatomy using 3D simulation software | |
| Scientific Title | Study of liver surgical anatomy using 3D simulation software | |
| Scientific Title:Acronym | Study of liver surgical anatomy using 3D simulation software | |
| Region |
|
|
| Condition | ||
| Condition | portal vein thrombosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | E-CT was performed on the first day after liver resection, and immediate anticoagulant therapy was started when PVT was detected. We assessed the frequency, predictive factors, and efficacy of early intervention for PVT. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Frequency of portal vein thrombosis
Effects and adverse events of anticoagulant therapy |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who underwent liver resection for primary liver cancer. | |||
| Key exclusion criteria | Metastatic liver cancer, bile duct or portal vein reconstruction, laparoscopic surgery, contrast medium allergy, renal dysfunction, or thrombus requiring anticoagulant therapy. | |||
| Target sample size | 400 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nihon University School of Medicine | ||||||
| Division name | Department of Digestive Surgery | ||||||
| Zip code | 1738610 | ||||||
| Address | 30-1 Oyaguchikami-machi, Itabashi-ku, Tokyo | ||||||
| TEL | +81-3-3972-8111 | ||||||
| yamazaki-nmed@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nihon University School of Medicine | ||||||
| Division name | Department of Digestive Surgery | ||||||
| Zip code | 1738610 | ||||||
| Address | 30-1 Oyaguchikami-machi, Itabashi-ku, Tokyo | ||||||
| TEL | +81-3-3972-8111 | ||||||
| Homepage URL | |||||||
| yoshida.nao@nihon-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nihon University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nihon University Itabashi Hospital |
| Address | 30-1 Oyaguchikami-machi, Itabashi-ku, Tokyo |
| Tel | +81-3-3972-8111 |
| +81-3-3972-8111 | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 235 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054018 |